In recent years, cases of Acute Flaccid Myelitis (AFM) have been on the rise, particularly in children, with spikes in 2014, 2016, and 2018. The D68 enterovirus strain is believed to be the primary cause of these cases. However, in 2020, during the Covid lockdown, the number of AFM cases drastically decreased, leading to speculation about the virus’s behavior. In 2022, as lockdowns were lifted, cases of D68 increased but did not result in the expected rise in AFM cases.
Dr. Kevin Messacar, an infectious disease specialist, noted the mystery surrounding the situation and theorized that the virus may have changed or that more people have developed immunity. Currently, 13 AFM cases have been confirmed in 2024, adding to the total of 758 cases since 2014.
One of the early cases of AFM was Vishnu Kagolanu, who lost the ability to move his arms and legs at the age of 7. Despite a grim prognosis, Vishnu underwent years of physical therapy and has been able to regain the ability to walk. While there is currently no specific treatment for AFM, researchers like Dr. Buddy Creech are working on developing a monoclonal antibody to stop the D68 virus.
Vishnu has since started a nonprofit called Neurostronger to raise awareness and funds for kids with neurological conditions. He remains hopeful and encourages others with AFM to find joy and overcome obstacles. The AFM cases serve as a reminder of the need for continued research and support for those affected by this debilitating condition.
Photo credit
www.nbcnews.com
